Otis CEO to Speak at Morgan Stanley Conference
Otis CEO to Speak at Morgan Stanley Conference
PR Newswire
FARMINGTON, Conn., Sept. 3, 2024
FARMINGTON, Conn., Sept. 3, 2024 /PRNewswire/ -- Otis Worldwide Corporation (NYSE: OTIS) Chair, CEO & President Judy Marks will participate in a fireside chat at the 12th annual Laguna conference hosted by Morgan Stanley on Thursday, September 12, 2024 at 2:35 p.m. PT (5:35 p.m. ET). The presentation will be broadcast live at www.otis.com.
About Otis
Otis is the world's leading elevator and escalator manufacturing, installation and service company. We move 2.3 billion people a day and maintain approximately 2.3 million customer units worldwide, the industry's largest Service portfolio. Headquartered in Connecticut, USA, Otis is 71,000 people strong, including 42,000 field professionals, all committed to meeting the diverse needs of our customers and passengers in more than 200 countries and territories worldwide. For more information, visit www.otis.com and follow us on LinkedIn, Instagram, and Facebook @OtisElevatorCo.
Media Contact: | Investor Relations Contact: |
Katy Padgett | Michael Rednor |
+1-860-674-3047 | +1-860-676-6011 |
View original content:https://www.prnewswire.com/news-releases/otis-ceo-to-speak-at-morgan-stanley-conference-302235279.html
SOURCE Otis Worldwide Corporation
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks